TAT Technologies Is Back: Q2 Revenue Surged 23%, but the Real Signal Is the $615M Backlog

Q2 shows TAT moving out of the Q1 squeeze

After a first-quarter revenue of $41.1 million and operating income of $3.0 million, TAT delivered Q2 revenue of $52.9 million, up 22.8%. That looks like more than a cosmetic bounce. It is the clearest sign yet that output is moving back toward demand once supply constraints eased.

The operating turn is visible in profit as well as revenue. TAT's Q2 operating income rose to $5.6 million, showing the rebound was not only about units coming through the system.

The backlog is the bigger tell. TAT ended the period with record backlog and long-term agreements of $615 million, while external commentary puts the range around $615 million to $650 million. Against that pipeline, the stock's muted reaction looks surprising.

Supply relief, not demand fatigue, drove the Q1-Q2 swing

The rebound was not random. TAT's first quarter was hurt by component part shortages and delayed deliveries from certain OEM suppliers. Once those bottlenecks loosened, results improved quickly.

That shows up in the numbers. TAT then posted Q2 revenue of $52.9 million, and first-half revenue rose 10.4% to $94.1 million. The sequence matters: demand was present, and the constraint eased.

The economics also improved. In Q2, gross profit rose 23.0% to $13.3 million, and gross margin reached 25.2%, up from 24.4% in Q1. That suggests better mix, better conversion, or both rather than a simple volume snapback.

Management was also explicit about the trade-offs involved. It said strategic prioritization of customer support led to targeted inventory investments and higher procurement costs. That reads less like a lucky quarter and more like a deliberate choice to protect service levels and future conversions, even at a short-term cost to profitability.

Honeywell deeper TAT's APU position

There is also more structural support now. TAT expanded its relationship with Honeywell Aerospace and became the sole global authorized distributor for spare parts for the 331-200/250 APU platform, with the MRO license extended to 2036.

That matters because it tightens TAT's control over a valuable service flow. If APU demand stays firm, those rights can support throughput and margin visibility well beyond this recovery cycle.

The market may still be underestimating the backlog conversion

The bull case is straightforward: a healthy aftermarket, clearer parts flow, and a record backlog that can convert into future revenue. The bear case is just as clear: one strong quarter does not prove the backlog will convert smoothly, especially if working capital stays elevated.

That is why the next few quarters matter. This is still a show-me story. Investors should watch whether backlog continues to turn into revenue and whether margins hold up as inventory normalization progresses.

What would confirm the setup from here

The stock's reaction to the quarter was contained despite record backlog and long-term agreements. That leaves room for reassessment if execution stays clean.

Ownership data can help confirm the tape. The next round of public disclosures and 13F filings should show whether institutional ownership is building. On the insider side, buying or flat positioning would support the recovery case; heavy selling as the backlog narrative strengthens would weaken it.

For now, the constructive view still depends on execution. If backlog converts and supply-chain pressures keep easing, TAT may deserve a closer look. If not, the recovery trade is not yet fully proven.